Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of lupatadine fumarate oral solution in children with allergic rhinitis
ChiCTR2500096423Phase 3Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rupatadine in allergic rhinitis (AR) (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Change in average rTNSS score within 14 days versus baseline. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
rupatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on ChiCTR2500096423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096423.